Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
How to Talk to Your Partner About Using PrEP

Talking about PrEP with your partner can open up a can of worms. Here's how to make the conversation as smooth as possible.

Published
27 January 2015
From
HIV Plus
Adherence packaging battles HIV/AIDS in Africa, India

Designed to help prevent the spread of HIV/AIDS in sub-Saharan Africa and India, MEMSCap smart electronic medication packaging system tracks each time the medication bottle is opened.

Published
26 January 2015
From
Packaging World
The tale of HIV “dirtiness”, gay sex, and society

After decades of education and advocacy, it would be reasonable to assume, that the notion of dirtiness in relation to HIV has diminished from our society. However, I would argue that this is not the case, especially if we look into dating apps / websites and the deployment of PrEP.

Published
26 January 2015
From
JZ (blog)
Drug Resistance, While Rare, Can Occur After Contracting HIV on PrEP

For the first time, a study has shown that, although rare, resistance to Truvada can develop if someone contracts HIV while taking the drug as PrEP.

Published
16 January 2015
From
AIDSMeds
Long-acting drug effectively prevents HIV-like infection in monkeys

Two new studies, including one conducted by researchers at the Aaron Diamond AIDS Research Center (ADARC) and Rockefeller University, published today (January 15) in Science Translational Medicine, show that long-acting cabotegravir injections are highly protective in a monkey model of vaginal transmission of a virus similar to HIV. This study was first reported by Aidsmap last year - see http://www.aidsmap.com/Monkey-studies-confirm-viability-of-injectable-PrEP-drug/page/2832825/ . A study in humans in now underway.

Published
16 January 2015
From
Rockefeller University press release
My Gonorrhea Nostalgia

A common objection to the use of pre-exposure prophylaxis (PrEP) is that taking a pill to prevent HIV does not guard against other STI’s and therefore condoms must continue to be used. But when did avoiding every possible STI become the new goal for gay sexual behavior? Syphilis, chlamydia, and gonorrhea are all easily treated and cured.

Published
14 January 2015
From
My Fabulous Disease
NYC Health Dept. Launches PrEP, PEP Outreach Campaign

To boost awareness of pre- and post-exposure prophylaxis (PrEP and PEP) to prevent HIV infection, the NYC Department of Health has launched an outreach program targeted to 600 doctors.

Published
14 January 2015
From
Poz magazine news
Gay men are better at predicting when they won’t have sex than when they will

A study in which a group of HIV-negative gay and bisexual men from New York were asked to predict each day whether they would have sex the

Published
12 January 2015
By
Gus Cairns
PrEP Version 1.1, 2.0, and Beyond

Peter Staley: The treatment to prevent HIV infections faces inaccurate comparisons to other meds and the same fearful objections as ‘the pill’ did in the ’60s.

Published
07 January 2015
From
The Advocate
PrEP works in women using injectable hormonal contraceptives and in their male sex partners

Preexposure prophylaxis (PrEP) with tenofovir or tenofovir/emtricitabine proved as effective in women using the injectable hormonal contraceptive depot medroxyprogesterone acetate (DMPA) as in women using no hormonal contraceptive. The same proved true of men whose female sex partners were using DMPA.

Published
07 January 2015
From
International AIDS Society
← First12345...49Next →

Filter by country